VENABLE LLP

Lobbying for GENEOSCOPY · Life sciences company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Missouri · House · Senate · $30,000.00 income · posted Oct 8, 2025

Lobbying activity 2

Health Issues

Increasing access to colorectal cancer screening; Medicare coverage of colorectal cancer screening tests; USPSTF colorectal cancer screening guidelines; Medicare Quality Measures

Budget/Appropriations

FY 2026 VA Appropriations Expanding colorectal cancer screening for veterans

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.